Report cover image

Galderma SA - Strategic SWOT Analysis Review

Publisher GlobalData
Published Jul 17, 2023
Length 46 Pages
SKU # GBDT18092219

Description

Galderma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Galderma SA (Galderma) develops and markets medical and consumer skin health products. The company provides prescription drugs and aesthetic solutions for the treatment of various skin conditions such as acne, rosacea, psoriasis and steroid-responsive dermatoses, nail mycosis, pigmentary disorders, skin cancer, atopic dermatitis, and sun protection among others. Its major brands include Epiduo, Differin, Oracea, Loceryl, Metvix, Azzalure/Dysport, Mirvaso, Soolantra, Restylane, Cetaphil, and Emervel. The company has its research and development centers and manufacturing sites in Asia-Pacific, the Middle East, Europe, Africa, and North and Latin America. Galderma is headquartered in Zug, Switzerland.

Galderma SA Key Recent Developments

Mar 13,2023: Galderma delivers strong FY 2022 growth driven by innovation and commercial performance
Jan 26,2023: Galderma announces the launch of FACE by Galderma – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction
Oct 13,2022: Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific
Sep 06,2022: GALDERMA showcases its continued commitment to innovation in dermatology with new data to be presented at 2022 EADV Congress

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

46 Pages
Section 1 - About the Company
Galderma SA - Key Facts
Galderma SA - Key Employees
Galderma SA - Key Employee Biographies
Galderma SA - Major Products and Services
Galderma SA - History
Galderma SA - Company Statement
Galderma SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Galderma SA - Business Description
Galderma SA - SWOT Analysis
SWOT Analysis - Overview
Galderma SA - Strengths
Galderma SA - Weaknesses
Galderma SA - Opportunities
Galderma SA - Threats
Galderma SA - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Galderma SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Galderma SA, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 13, 2023: Galderma delivers strong FY 2022 growth driven by innovation and commercial performance
Jan 26, 2023: Galderma announces the launch of FACE by Galderma – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction
Oct 13, 2022: Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific
Sep 06, 2022: GALDERMA showcases its continued commitment to innovation in dermatology with new data to be presented at 2022 EADV Congress
Aug 25, 2022: Galderma Delivers Strong H1 2022 Results and Continued Innovation Across Its Leading Dermatology Portfolio
Jun 11, 2022: Galderma Announces Positive Results in Two Phase III Studies for a Novel Liquid Formulation botulinumtoxinA (RelabotulinumtoxinA) for the Treatment of Glabellar Lines (frown) and Lateral Canthal Lines (crow’s Feet)
May 31, 2022: Galderma to present extensive new clinical data across its portfolio of neuromodulators, fillers and biostimulators at the IMCAS World Congress 2022
Apr 05, 2022: Galderma launches a virtual experience this Rosacea Awareness Month showcasing how the condition goes beyond the visible with Rosacea Space
Mar 28, 2022: Galderma to present new clinical data and high patient satisfaction across their portfolio of dermal fillers, collagen biostimulators and liquid neuromodulators at AMWC 2022
Mar 25, 2022: Galderma to highlight latest science and innovation across its product portfolio at the 2022 AAD Annual Meeting
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Galderma SA, Key Facts
Galderma SA, Key Employees
Galderma SA, Key Employee Biographies
Galderma SA, Major Products and Services
Galderma SA, History
Galderma SA, Subsidiaries
Galderma SA, Key Competitors
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Galderma SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Galderma SA, Recent Deals Summary
List of Figures
Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Galderma SA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us